Login / Signup

The pipeline of immunomodulatory therapies in polymyalgia rheumatica and giant cell arteritis: A systematic review of clinical trials.

Lou KawkaBaptiste ChevetLaurent ArnaudGuillaume BeckerGuillermo Carvajal AlegriaRenaud Felten
Published in: Autoimmunity reviews (2024)
This systematic review identified 23 DMARDs evaluated for PMR and GCA: 3 csDMARDs, 17 bDMARDs and 3 tsDMARDs. Several promising treatments are likely to be marketed in the coming years.
Keyphrases
  • giant cell
  • systematic review
  • clinical trial
  • meta analyses
  • randomized controlled trial
  • rheumatoid arthritis patients
  • open label